Severe intoxication by 3,4 -methylenedioximethamphetamine (MDMA). Case report
DOI:
https://doi.org/10.53732/rccsalud/2024.e6210Keywords:
N-Methyl-3,4-methylenedioxyamphetamine, sympathomimetics, poisoning, serotonergicAbstract
3,4-methylenedioxymethamphetamine (MDMA) intoxication, has had a dramatic resurgence since 1980, has spread throughout much of the United States, Europe and America, has been widely used as a recreational drug, currently Synthetic cathinones are they sell as "legal highs" to circumvent existing laws, resulting in severe toxicity and deaths. We present a clinical case of a young adult, who debuted with severe acute MDMA poisoning, with multiple organ failure, who underwent care and acute management of the poisoning in the emergency department, with subsequent management of complications in the intensive care unit and finally with survival despite the poor prognosis.
References
Vogels N, Brunt TM, Rigter S, van Dijk P, Vervaeke H, Niesink RJ. Content of ecstasy in the Netherlands: 1993-2008. Addiction. 2009;104(12):2057-66. https://doi.org/10.1111/j.1360-0443.2009.02707.x
White JM, Bochner F, Irvine RJ. The agony of "ecstasy". Med J Aust. 1997;166(3):117-8. https://doi.org/10.5694/j.1326-5377.1997.tb140037.x
Gough B, Ali SF, Slikker W Jr, Holson RR. Acute effects of 3,4-methylenedioxymethamphetamine (MDMA) on monoamines in rat caudate. Pharmacol Biochem Behav. 1991;39(3):619-23. https://doi.org/10.1016/0091-3057(91)90137-Q
Robledo P. Las anfetaminas. Trastornos Adictivos, 2008;10(3):166–174. https://doi.org/10.1016/S1575-0973(08)76363-3
Lewis N, Howland M, Lewis N, Smith S, Goldman L, Hoffman R. Amphetamines. In Goldfrank’s Toxicologic Emergencies. 11th ed. 2009. 1099-1107 pp.
Henry JA, Jeffreys KJ, Dawling S. Toxicity and deaths from 3,4-methylenedioxymethamphetamine (“ecstasy”). The Lancet. 1992; 340(8816):384–387. https://doi.org/10.1016/0140-6736(92)91469-O
Paratz ED, Cunningham N, MacIsaac AI. The Cardiac Complications of Methamphetamines. Heart, Lung and Circulation. 2015;25(4):325–332. https://doi.org/10.1016/j.hlc.2015.10.019
Herr RD, Caravati EM. Acute transient ischemic colitis after oral methamphetamine ingestion. The American Journal of Emergency Medicine. 1991;9(4):406–409. https://doi.org/10.1016/0735-6757(91)90073-s
Jones, Simpson. Review article: mechanisms and management of hepatotoxicity in ecstasy (MDMA) and amphetamine intoxications. Alimentary Pharmacology and Therapeutics. 1999;13(2):129–133. https://doi.org/10.1046/j.1365-2036.1999.00454.x
Eskandari MR, Rahmati M, Khajeamiri AR, Kobarfard F, Noubarani M, Heidari H. A new approach on methamphetamine-induced hepatotoxicity: involvement of mitochondrial dysfunction. Xenobiotica, 2013;44(1):70–76. https://doi.org/10.3109/00498254.2013.807958
Matsumoto RR, Seminerio MJ, Turner RC, Robson MJ, Nguyen L, Miller DB, et al. Methamphetamine-induced toxicity: An updated review on issues related to hyperthermia. Pharmacology & Therapeutics, 2014;144(1):28–40. https://doi.org/10.1016/j.pharmthera.2014.05.001
Richards JR, Johnson EB, Stark RW, Derlet RW. Methamphetamine abuse and rhabdomyolysis in the ED: A 5-year study. The American Journal of Emergency Medicine, 1999;17(7):681–685. https://doi.org/10.1016/s0735-6757(99)90159-6
Bryden AA, Rothwell PJ, O'Reilly PH. Urinary retention with misuse of "ecstasy". BMJ. 1995;310(6978):504. https://doi.org/10.1136/bmj.310.6978.504a
Abuso de la MDMA (éxtasis) - Reporte de investigación. In National Institute on Drug Abuse. 2021.
Fallon JK, Shah D, Kicman AT, Hutt AJ, Henry JA, Cowan DA, Forsling M. Action of MDMA (ecstasy) and its metabolites on arginine vasopressin release. Ann N Y Acad Sci. 2002;965(1):399-409. https://doi.org/10.1111/j.1749-6632.2002.tb04181.x
Derlet RW, Rice P, Zane Horowitz B, Lord RV. Amphetamine toxicity: Experience with 127 cases. The Journal of Emergency Medicine. 1989;7(2):157–161. https://doi.org/10.1016/0736-4679(89)90263-1
Solursh LP. Use of diazepam in hallucinogenic drug crises. JAMA. 1968;205(9):644. https://pubmed.ncbi.nlm.nih.gov/5695106/
Wu CS, Tsai YT, Tsai HJ. Antipsychotic Drugs and the Risk of Ventricular Arrhythmia and/or Sudden Cardiac Death: A Nation‐wide Case‐Crossover Study. J A Heart Assoc. 2015;4(2):e001568. https://doi.org/10.1161/jaha.114.001568
Muench J, Hamer AM. Adverse effects of antipsychotic medications. Am Fam Physician. 2010;81(5):617-22. https://www.aafp.org/pubs/afp/issues/2010/0301/p617.html
Laskowski LK, Landry A, Vassallo SU, Hoffman RS. Ice water submersion for rapid cooling in severe drug-induced hyperthermia. Clinical Toxicology. 2015;53(3):181–184. https://doi.org/10.3109/15563650.2015.1009994
Grunau BE, Wiens MO, Brubacher JR. Dantrolene in the treatment of MDMA-related hyperpyrexia: a systematic review. CJEM, 2010;12(5):435–442. https://doi.org/10.1017/s1481803500012598
Kolb ME, Horne ML, Martz, R. Dantrolene in human malignant hyperthermia a multicenter study. Anesthesiology. 1982;56(4):254–262. https://doi.org/10.1097/00000542-198204000-00005
McKinney PE, Tomaszewski C, Phillips S, Brent J, Kulig K. Methamphetamine toxicity Prevented by activated charcoal in a mouse model. Annals of Emergency Medicine. 1994;24(2):220–223. https://doi.org/10.1016/s0196-0644(94)70133-4.
Li J, Li J, Chen Y, Xu Y, Li W, Chen Y, et al. Methamphetamine use associated with monomorphic ventricular Tachycardia. J Addict Med. 2014;8(6):470–473. https://doi.org/10.1097/adm.0000000000000069
Jacobs W. Fatal amphetamine-associated cardiotoxicity and its medicolegal implications. Am J Forensic Med Pathol. 2006;27(2):156-60. https://doi.org/10.1097/01.paf.0000188082.68009.10
Bowen JS. Diffuse Vascular Spasm Associated with 4-Bromo-2,5-Dimethoxyamphetamine Ingestion. JAMA. 1983;249(11):1477. https://jamanetwork.com/journals/jama/article-abstract/384921